← back to search

Anthony E. Lang

Istituti di Ricovero e Cura a Carattere Scientifico · CA
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
ALS Alzheimer’s Disease Frontotemporal Dementia Dementia with Lewy Bodies Parkinson's Prion Diseases Research Faculty Graham Collingridge
h-index
166
citations
141,730
works
1,536
NIH funding
primary concept
email

Recent publications

Tics and Tic-Like Phenomena as Compulsive Acts.
2026cited by 0position: contributordoi
Correction: Revisiting Parkinson's disease definition and classification: insights from two emerging biological frameworks.
2026cited by 0position: contributordoi
The "Hallett Sign" of Functional Jerky Movement Disorder.
2026cited by 0position: contributordoi
Addressing Care Partner Burden from the Underrecognition of Iatrogenic Sexual Behavior Changes in Parkinson's Disease.
2026cited by 0position: contributordoi
CSF α-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge Gaps.
2026cited by 0position: contributordoi
Subcortical white matter hyperintensities and motor function in parkinson's disease: findings from the ONDRI study.
2026cited by 0position: contributordoi
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism
Nature Medicine 2026cited by 0position: contributordoi
Socioeconomic and healthcare disparities in climate-related vulnerability for Parkinson’s disease and movement disorders
International Review of Movement Disorders 2026cited by 0position: contributordoi
Definition and Classification of Dystonia
Movement Disorders 2025cited by 75position: middledoi
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases
Neurology 2025cited by 20position: middledoi
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases.
2025cited by 14position: contributordoi
Distinct Longitudinal Clinical‐Neuroanatomical Trajectories in Parkinson's Disease Clinical Subtypes: Insight toward Precision Medicine
Movement Disorders 2025cited by 11position: middledoi
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing
Annals of Clinical and Translational Neurology 2025cited by 9position: middledoi
SynNeurGe: The road ahead for a biological definition of Parkinson's disease.
2025cited by 4position: contributordoi
Initial biological classification of Lewy body diseases: No consensus on terminology.
2025cited by 3position: contributordoi
Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome.
2025cited by 2position: contributordoi
The Impact of Neuropsychiatric Symptoms in Perceived Quality of Life in Patients With Progressive Supranuclear Palsy.
2025cited by 2position: contributordoi
How do I Know That the Jerks I See Are Tics?
2025cited by 1position: contributordoi
Tremor in Pediatric Populations: Clinical Characteristics, Differential Diagnosis, and Management Challenges.
2025cited by 1position: contributordoi
AOPEP-Related Dystonia with Supranuclear Vertical Gaze Palsy.
2025cited by 1position: contributordoi
Prevalence of Parkinson's Disease in 22q11.2 Deletion Syndrome: A Multicenter Study.
2025cited by 1position: contributordoi
Dissecting the Phenotypic Spectrum and Complexity of Movement Disorders in 22q11.2 Deletion Syndrome.
2025cited by 1position: contributordoi
Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study.
2025cited by 1position: contributordoi
How Do I Do a Skin Punch Biopsy for Research and Diagnostic Purposes in Parkinson's Disease and Atypical Parkinsonism?
2025cited by 0position: contributordoi
A Pragmatic Approach to Sexual Health in Movement Disorders.
2025cited by 0position: contributordoi
Various Gait Patterns in Chorea-Acanthocytosis.
2025cited by 0position: contributordoi
Revisiting Parkinson's disease definition and classification: insights from two emerging biological frameworks.
2025cited by 0position: contributordoi
Teaching NeuroImage: Clinicoradiologic Clues in Aceruloplasminemia.
2025cited by 0position: contributordoi
Levodopa‐Carbidopa Intestinal Gel in an Outpatient Setting: A 10‐Year Experience
Movement Disorders Clinical Practice 2025cited by 0position: middledoi
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease.
2024cited by 64position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 80 papers (2019–2026)Alberto J. Espay · University of Cincinnati11 papers (2014–2022)Irene Litvan · Johns Hopkins University9 papers (2014–2022)Glenda M. Halliday · Mind Australia8 papers (2014–2024)Daniela Berg · Christian-Albrechts-Universität zu Kiel7 papers (2014–2020)Victor S.C. Fung · The University of Sydney7 papers (2013–2025)Ronald B. Postuma · Montreal Neurological Institute and Hospital7 papers (2014–2025)Werner Poewe · Management Center Innsbruck7 papers (2014–2022)Nikolai Gil D. Reyes · University of Cartagena7 papers (2023–2026)Gabor G. Kovacs · Mahindra and Mahindra Limited (India)7 papers (2022–2025)Christine Klein · Indiana University – Purdue University Indianapolis6 papers (2013–2025)Thomas Gasser · Luxembourg Institute of Health6 papers (2014–2024)Joseph Jankovic · Phillips University6 papers (2013–2026)Günther Deuschl · John Wiley & Sons (United States)6 papers (2014–2024)Caroline M. Tanner · San Francisco VA Medical Center6 papers (2012–2020)C. Warren Olanow · Icahn School of Medicine at Mount Sinai6 papers (2013–2016)Kailash P. Bhatia · University of Zurich6 papers (2013–2025)Günter Höglinger · Icahn School of Medicine at Mount Sinai6 papers (2019–2026)Alberto J. Espay · University of Pennsylvania6 papers (2019–2020)Christopher G. Goetz · Rush University Medical Center5 papers (2015–2018)